Congenital Heart Disease Clinical Trial
Official title:
Pediatric Cardiac Surgery Pre-operative Counselling Study
We have developed a pre-operative educational / counselling booklet with the focus on
informing parents / patients about the different stages before, during, and after cardiac
surgery that they will encounter; both chronologically and emotionally. With this approach
and study our objectives are:
1. To provide anticipatory guidance for parents to decrease parental stress and improve
parental experience and preparedness, thus involving the parent as a partner in caring for
their child.
We hypothesize that this additional tool will improve parental satisfaction in regards to
being prepared for their child's heart surgery.
Our study objectives are to provide anticipatory guidance for parents to decrease parental
stress and improve parental experience and preparedness, thus involving the parent as a
partner in caring for their child.
A Case-control trial comparing family satisfaction between families that did and did not
receive the STAGES-booklet.
Primary endpoints are Family satisfaction score and Family stress score. Secondary endpoints
are Percentage of families that would recommend the STAGES-booklet as routine pre-operative
educational tool, as well as Family Stress score during each stage as outlined in the
STAGES-booklet
The Study period either 1 year or once 100 participants enrolled have completed their
post-operative survey
Methods Group allocation: The first 50 families will be assigned to the STAGES-post group,
and the last 50 to the STAGES-pre group. In both groups participants will be blinded to
their timing of exposure to the intervention. This randomization in an attempt to minimize
educator bias of possibly giving the STAGES-post group information pertaining to the
intervention proposed.
Time points: Routinely after the cardiologist informs families that their child has a
cardiac condition needing intervention, the Variety Children's Heart Centre clinical
resource nurses, meet with families to help them navigate through upcoming events, do
pre-operative counselling and supply them with educational material. At this point parents
will be asked in a sensitive manner, whether they would consent to taking part in this study
(see consent form). The first 50 will be informed that they will receive a booklet (not
disclosing the STAGES-booklet) post-operatively to evaluate and a survey to complete
post-operatively. The subsequent 50 families will be given the STAGES-booklet (not
disclosing that STAGES is the interventional tool being investigated) together with the
other routine educational material, and be counselled according to the STAGES-philosophy.
Before leaving the province for cardiac surgery, the RN's will in addition to logistical
matters, repeat the STAGES-booklet review and teaching with the STAGES-pre group.During the
routine post-operative visit at 6-12 weeks, families will be warned that their visit will be
approximately 20-30 minutes longer to complete the post-operative evaluation-survey. The
STAGES-post group will be given the STAGES-booklet and informed of the STAGES-philosophy
before completing the post-operative survey.In both groups, parents will receive condition
specific teaching that is part of routine care currently.
Data collection : Surveys will contain only the family's study number in order to remain
anonymous. Data will be analyzed collectively at the end of the study.
Survey responses will be aggregated and appropriate statistical analysis performed by the
CHARM statistician.
Expected outcomes:Mean Family satisfaction scores will be 10-20% higher, and mean emotional
stress scores 10-20% lower in the STAGES-pre group compared to the STAGES-post group. More
than 80% of families in each group will recommend the STAGES-booklet and/or philosophy to be
used as a routine pre-operative tool.
Results will be published in a respectable influential journal, submitted to national and
international conferences, with the goal to promote the use of STAGES, across Canada and
internationally.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04992793 -
Paediatric Brain Injury Following Cardiac Interventions
|
||
Recruiting |
NCT05213598 -
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
|
||
Completed |
NCT04136379 -
Comparison of Home and Standard Clinic Monitoring of INR in Patients With CHD
|
||
Completed |
NCT04814888 -
3D Airway Model for Pediatric Patients
|
||
Recruiting |
NCT04920643 -
High-exchange ULTrafiltration to Enhance Recovery After Pediatric Cardiac Surgery
|
N/A | |
Completed |
NCT05934578 -
Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training
|
N/A | |
Recruiting |
NCT06041685 -
Effect of Local Warming for Arterial Catheterization in Pediatric Anesthesia
|
N/A | |
Recruiting |
NCT05902013 -
Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation
|
N/A | |
Not yet recruiting |
NCT05687292 -
Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery
|
||
Not yet recruiting |
NCT05524324 -
Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT
|
N/A | |
Completed |
NCT02746029 -
Cardiac Murmurs in Children: Predictive Value of Cardiac Markers
|
||
Completed |
NCT02537392 -
Multi-micronutrient Supplementation During Peri-conception and Congenital Heart Disease
|
N/A | |
Completed |
NCT03119090 -
Fontan Imaging Biomarkers (FIB) Study
|
||
Recruiting |
NCT02258724 -
Swiss National Registry of Grown up Congenital Heart Disease Patients
|
||
Terminated |
NCT02046135 -
Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery
|
Phase 2 | |
Completed |
NCT01966237 -
Milrinone Pharmacokinetics and Acute Kidney Injury
|
||
Recruiting |
NCT01184404 -
Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery
|
N/A | |
Completed |
NCT01548950 -
Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension
|
N/A | |
Completed |
NCT01178710 -
Effect of Simvastatin on Cardiac Function
|
N/A |